Fund Evaluator:
Regan Fixed Rate MBS ETF (MBSX)Fixed Income
Global Asset Class
Taxable Bond
Fund Group
Intermediate Government
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.40% F
Expense Ratio
$17 Mil
Assets
Open
Status
0.00%
12b-1 Fee
2.08%
TTM Yield
0.00%
Max Load
na
Portfolio Turnover
Best Performing in Intermediate Government Over the Last Year
| 3.8% | Victory Government Securities (USGNX) |
| 3.6% | American Century Government Bond Inv (CPTNX) |
| 3.5% | PGIM Government Income Z (PGVZX) |
| 3.4% | Fidelity Advisor Government Income Z (FIKPX) |
| 3.3% | Fidelity Government Income (FGOVX) |
Data as of 6/30/2026
0.5% A
1-Mo Return
1.3% A
3-Mo Return
2.3% A
YTD Return
7.7% A
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Regan Capital
Inception Date
4/30/2025
Share Class Type
Equity Investment Style
na
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
N/A: 100%
Additional Fund Details
Regan Fixed Rate MBS ETF Overview
MBSX Trailing NAV Total Returns Data as of 6/30/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| MBSX Return (NAV) | 0.5% | 1.3% | 7.7% | na | na | na |
| MBSX Grade | A | A | A | na | na | na |
| +/- Category | 0.3% | 1.1% | 4.9% | na | na | na |
| Intermediate Government Avg | 0.2% | 0.2% | 2.8% | 3.4% | -0.3% | 0.8% |
| MBSX Tax Cost Ratio | na | na | 1.5% | na | na | na |
MBSX Annual NAV Total ReturnsData as of 6/30/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| MBSX Return (NAV) | 2.3% | na | na | na | na | na | na | na | na | na | na |
| MBSX Grade | A | na | na | na | na | na | na | na | na | na | na |
| +/- Category | 2.2% | na | na | na | na | na | na | na | na | na | na |
| Intermediate Government Avg | 0.1% | 6.9% | 0.7% | 3.8% | -11.8% | -2.0% | 7.3% | 5.9% | 0.5% | 1.8% | 0.8% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | na |
| Bond Investment Style: | na |
| Yield: | 2.1% |
| Dividend Distribution: | Monthly |
| Cap Gains Distribution: | Annually |
| Total Assets: | $17 Mil |
| Fund Total Assets: | $ 17 Mil |
| Share Class Type: | |
| Portfolio Turnover: | na |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 1.2 years | |||
| Average Tenure: 1.2 years | |||
| Managers (Year): Weinand Skyler (2025), Hall Chris (2025) | |||
Portfolio Composition (as of 6/30/26)
| # of Holdings: | 91 |
| % in Top 10 Holdings: | 66.8% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 0.0% |
Portfolio Allocation |
|
| Domestic Stock: | 0.0% |
| Foreign Stock: | 0.0% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 60.3% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 1.8% |
| Cash: | 37.9% |
Purchase Information
| Fund Family: | Regan Capital |
| Phone Number: | 800-617-0004 |
| Website: |
| Status: | Open |
| Inception Date: | April 30, 2025 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.00% |
Expenses and Fees | |
| Expense Ratio (%): | 0.40% ( Rating : Avg ) |
| Category Average Expense Ratio (%): | 0.61% |
| Share Class: | Regan Fixed Rate MBS ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.